(Total Views: 1239)
Posted On: 02/25/2021 4:07:28 AM
Post# of 146
$NWBO DD (opinion) Post by 10baggerz "copy" Wow! The silence from NWBO has been brutal but the pieces of information obtained by people on this board sure paint a pretty clear picture:
Endpoint revisions buy-in
Historical control buy-in and FDA guidance
One SAP confirmed in writing by DI
Manufacturing capabilities ramped-up (CRL, Advent, Sawston, Flaskworks)
CRL purchase of Cognate for well over current value
Use of DCVax-L in combo trials at UCLA with MERCK Keytruda!
Relationships between NWBO and potential partners like Merck, CRL, etc
Manufacturing and use of DCVax-L by Advent at Sawston for compassionate use
Journal publication info/timeline
Warrant holders by and large NOT exercising or selling (see float and volume)
Models of actual interim data confirming OS statistical significance
Feel free to add any more!
If I were an actual short right now I’d be looking to cover ASAP.
Endpoint revisions buy-in
Historical control buy-in and FDA guidance
One SAP confirmed in writing by DI
Manufacturing capabilities ramped-up (CRL, Advent, Sawston, Flaskworks)
CRL purchase of Cognate for well over current value
Use of DCVax-L in combo trials at UCLA with MERCK Keytruda!
Relationships between NWBO and potential partners like Merck, CRL, etc
Manufacturing and use of DCVax-L by Advent at Sawston for compassionate use
Journal publication info/timeline
Warrant holders by and large NOT exercising or selling (see float and volume)
Models of actual interim data confirming OS statistical significance
Feel free to add any more!
If I were an actual short right now I’d be looking to cover ASAP.
(0)
(0)
$MJ
